Cargando…

Predictive Value of Isolated Symptoms for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children Tested During Peak Circulation of the Delta Variant( )

BACKGROUND: Coronavirus disease 2019 (COVID-19) testing policies for symptomatic children attending US schools or daycare vary, and whether isolated symptoms should prompt testing is unclear. We evaluated children presenting for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Westbrook, Adrianna L, Benedit, Laura C, Frediani, Jennifer K, Griffiths, Mark A, Khan, Nabeel Y, Levy, Joshua M, Morris, Claudia R, Rostad, Christina A, Stone, Cheryl L, Sullivan, Julie, Vos, Miriam B, Welsh, Jean, Wood, Anna, Martin, Greg S, Lam, Wilbur, Pollock, Nira R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992302/ https://www.ncbi.nlm.nih.gov/pubmed/35271694 http://dx.doi.org/10.1093/cid/ciac112

Ejemplares similares

The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs
por: Frediani, Jennifer K., et al.
Publicado: (2023)

The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons
por: Rajasingham, Radha, et al.
Publicado: (2017)

Sensitivity of Rapid Antigen Tests Against SARS-CoV-2 Omicron and Delta Variants
por: Rao, Anuradha, et al.
Publicado: (2023)

Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants
por: Rao, Anuradha, et al.
Publicado: (2023)

Respiratory Coinfections in Children With SARS-CoV-2
por: Westbrook, Adrianna, et al.
Publicado: (2023)

Prevalence of SARS-CoV-2 in hemoglobinopathies is modified by age and race
por: Frediani, Jennifer K., et al.
Publicado: (2023)

SARS-CoV-2 reliably detected in frozen saliva samples stored up to one year
por: Frediani, Jennifer K., et al.
Publicado: (2022)

The Significance of Lactate and Lipid Peaks for Predicting Primary Neuroepithelial Tumor Grade with Proton MR Spectroscopy
por: Nakamura, Hisao, et al.
Publicado: (2017)

Cat Scratch Disease: 9 Years of Experience at a Pediatric Center
por: Amin, Omayma, et al.
Publicado: (2022)

Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection
por: Alonso, Carolyn D, et al.
Publicado: (2021)

The $\Delta$ in the nuclear quasi-elastic peak
por: Alberico, W M, et al.
Publicado: (1989)

Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients
por: Banegas, Marcela, et al.
Publicado: (2023)

Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection( )
por: Verkerke, Hans P, et al.
Publicado: (2022)

Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant
por: Risk, Malcolm, et al.
Publicado: (2022)

Severe Fatigue and Persistent Symptoms at 3 Months Following Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study
por: Gottlieb, Michael, et al.
Publicado: (2023)

Performance and Operational Evaluation of the Access Bio CareStart Rapid Antigen Test in a High-Throughput Drive-Through Community Testing Site in Massachusetts
por: Pollock, Nira R, et al.
Publicado: (2021)

Other Respiratory Viruses Are Important Contributors to Adult Respiratory Hospitalizations and Mortality Even During Peak Weeks of the Influenza Season
por: Gilca, Rodica, et al.
Publicado: (2014)

Severe Acute Respiratory Syndrome Coronavirus 2 Delta Vaccine Breakthrough Transmissibility in Alachua County, Florida
por: Rife Magalis, Brittany, et al.
Publicado: (2022)

Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital
por: Dodge, Maura C, et al.
Publicado: (2023)

Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation
por: Brown, Michael, et al.
Publicado: (2022)

Impact of Casirivimab-Imdevimab on Severe Acute Respiratory Syndrome Coronavirus 2 Delta Variant Nasopharyngeal Virus Load and Spike Quasispecies
por: Vellas, Camille, et al.
Publicado: (2022)

Antibody Level Predicts the Clinical Course of Breakthrough Infection of COVID-19 Caused by Delta and Omicron Variants: A Prospective Cross-Sectional Study
por: Kim, Min Hyung, et al.
Publicado: (2022)

Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay( )
por: Sigal, George B, et al.
Publicado: (2022)

Association between self-reported masking behavior and SARS-CoV-2 infection wanes from Pre-Delta to Omicron-predominant periods — North Carolina COVID-19 Community Research Partnership (NC-CCRP)
por: Tjaden, Ashley H., et al.
Publicado: (2023)

Myocarditis Following Coronavirus Disease 2019 mRNA Vaccine: A Case Series and Incidence Rate Determination
por: Perez, Yalile, et al.
Publicado: (2021)

Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022
por: Hoeve, Christina E, et al.
Publicado: (2023)

Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2
por: Fintzi, Jonathan, et al.
Publicado: (2022)

Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) Infection
por: Al-Obaidi, Mohanad M, et al.
Publicado: (2022)

BNT162b2 Effectiveness Against Delta and Omicron Variants of Severe Acute Respiratory Syndrome Coronavirus 2 in Adolescents Aged 12–17 Years, by Dosing Interval and Duration
por: Ionescu, Iulia G, et al.
Publicado: (2023)

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)

An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
por: Roe, Molly K, et al.
Publicado: (2022)

Metabolomics profiling in acute liver transplant rejection in a pediatric population
por: Frediani, Jennifer K., et al.
Publicado: (2022)

Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
por: Huai Luo, Chun, et al.
Publicado: (2021)

Impact of repeated nasal sampling on detection and quantification of SARS-CoV-2
por: Levy, Joshua M., et al.
Publicado: (2021)

SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise
por: Shook, Lydia L, et al.
Publicado: (2022)

Risk Factors for Septicemia Deaths and Disparities in a Longitudinal US Cohort
por: Kempker, Jordan A, et al.
Publicado: (2018)

Potential Influence of Staphylococcus aureus Clonal Complex 30 Genotype and Transcriptome on Hematogenous Infections
por: Sharma-Kuinkel, Batu K., et al.
Publicado: (2015)

Methods of Inactivation of SARS-CoV-2 for Downstream Biological Assays
por: Patterson, Edward I, et al.
Publicado: (2020)

Opportunities and challenges in utilizing electronic health records for infection surveillance, prevention, and control
por: Atreja, Ashish, et al.
Publicado: (2008)

Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)
por: Maeda, Haruka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h6fpp25np7ghs0jglffjust3au